Tower View Wealth Management LLC / VRTX
Tower View Wealth Management LLC’s Vertex Pharmaceuticals Inc Position
Does Tower View Wealth Management LLC own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 5.2K shares worth $2M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q2 2025
Shares
5.2K
% of Portfolio
+1.20%
Quarters Held
13
position exited
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 5.2K | $2M | +1.20% |
| Q1 2025 | 5.1K | $2M | +1.45% |
| Q4 2024 | 5.1K | $2M | +1.09% |
| Q3 2024 | 4.9K | $2M | +1.24% |
| Q2 2024 | 4.8K | $2M | +1.29% |
| Q1 2024 | 4.8K | $2M | +1.17% |
| Q4 2023 | 4.7K | $1,929 | +1.20% |
| Q3 2023 | 4.7K | $1,628 | +1.14% |
| Q2 2023 | 4.7K | $1,643 | +1.11% |
| Q1 2021 | 6.5K | $1M | +0.77% |
| Q4 2020 | 6.3K | $1M | +0.85% |
| Q3 2020 | 6.2K | $2M | +1.10% |
| Q2 2020 | 6.1K | $2M | +1.30% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tower View Wealth Management LLC’s full portfolio or all institutional holders of VRTX.